Subscribe Register Login
Monday, April 23, 2018, 12:54 p.m.

This exclusive story is reserved for our subscribers.

Support independent journalism by subscribing to the Arkansas Democrat-Gazette.

Subscribe now to continue reading.

Drug sales lift Johnson & Johnson profits

Johnson & Johnson's new hepatitis C drug Olysio is on the way to blockbuster sales in its first year, helping the drugmaker raise its 2014 earnings forecast for the second quarter in a row.

Click here to login or subscribe below.

BEST DEAL
7-Day
Home Delivery
& Online
Online Only
Get Started Get Started
Breaking News
Commenting
Newspaper Content Online
Smartphone Access
Tablet App (iPad) Access
Home Delivery
Sunday Comics, Ad Inserts, Coupons